At a glance
ClinicalIndex Comparison RecordN/ACompleted· 135 enrolled
Drug / intervention
Intervention/treatmentdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Reduce Ventricular Pacing Using Ventricular Intrinsic Preference: VIP™ Study
In Brief
A clinical study evaluating Intervention/treatment for Bradycardia. Completed, enrolled 135 participants across 1 site.
Detailed Summary
The purpose of this study is to evaluate the efficacy of the VIP™ feature (available in dual chamber Victory® devices) to reduce unnecessary RV pacing, and to determine if patients with implanted SJM pacemakers will benefit by using VIP™ rather than only a programmed AV/PV delay.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsBradycardia
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
2006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartFeb 2006
First PostedApr 2006
Primary CompletionSep 2008
TodayJul 2026
First PostedApr 5, 2006
Enrollment StartFeb 1, 2006
Primary CompletionSep 1, 2008
TodayJul 2, 2026
Enrollment to primary: 2.6 yearsPosted 20.2 years ago
Interventions
Intervention/treatmentdevice
Device: VIP On Device: VIP Off